Skip to main content
Premium Trial:

Request an Annual Quote





As BioInform went to press last week, Pharmacopeia and Eos Biotechnology announced that they had called off their plans to merge. Further details were not immediately available.

Earlier in the week, Pharmacopeia of Princeton, NJ, said it expects software revenues for its Accelrys unit to be about $34 million and $95 million, for the fourth quarter and full year 2001, respectively.

This represents revenue growth of 26 percent for 2001 for the software division, including the effects of acquisitions. For the fourth quarter, software revenue growth was 9 percent. This includes a 21 percent increase in software revenues in the United States and Europe, partially offset by a 22 percent decline in fourth-quarter software revenues in Asia.

The company expects to release its actual financial results in early- to mid-February.




Genteon of San Diego, Calif., and Advanced Chemistry Development of Toronto have agreed to integrate ACD’s ACD/GeneManager software with Genteon’s Capella 400 384-capillary electrophoresis system for DNA polymorphism analysis.

ACD said it has developed special versions of the software based on Genteon’s internal standards for SNP analysis and DNA fragment length analysis with the Capella 400.


MDL Information Systems and Partek have signed a three-year agreement under which MDL becomes the exclusive, worldwide marketer of St. Louis, Mo.-based Partek’s data analysis and visualization software.

MDL, headquartered in San Leandro, Calif., will also provide technical pre-sales, training, and consulting services for the products under the agreement, which covers Partek Pro, Partek Discover, Partek Infer, Partek Predict, and Partek Connect.


South San Francisco, Calif.-based diaDexus will use Compugen’s LEADS computational biology platform in its efforts to develop human diagnostic and therapeutic products.

Under the terms of the agreement, Compugen of Tel Aviv, Israel, will receive undisclosed cash payments and a warrant to purchase equity in diaDexus.


Paracel, based in Pasadena, Calif., said last week that Hyseq Pharmaceuticals has purchased two BlastMachine systems.

Hyseq plans to use the systems in several projects, including editing assembled cDNA fragments into full-length genes, annotation of Hyseq proprietary genes against public domain databases, and expression analysis comparing cDNA sequences with Hyseq and dbEST databases.




Prevas Bioinformatics of Stockholm, Sweden, said last week that it has been hired to create a data management system for Biovitrum, also based in Stockholm. The project, which will integrate data from different stages in the research process, will take 60 man-weeks, according to Prevas.



Cenk Sahinalp, an assistant professor in the electrical engineering and computer science department of Case Western Reserve University, was awarded an NSF grant for the project, “Algorithmic Methods for Large Scale Genome Analysis.”

The expected award amount of $330,000 will go toward development of “algorithms and software tools for discovery, resolution, and evolutionary analysis of genomic duplications and other genome-wide segmental rearrangements,” according to the grant proposal.

The award will also support a new advanced-level graduate course in computational genomics at the university.


John Jungck, a professor of biology at Beloit College, was awarded an NSF grant estimated at $1,414,857 for “Bioinformatics Education Dissemination: Reaching Out, Connecting, and Knitting-together (BEDROCK),” an effort to redesign the undergraduate biology curricula to reflect current advances in bioinformatics.

BEDROCK’s project goals include identifying faculty who can take a leadership role in bioinformatics education; identifying innovative approaches to incorporating bioinformatics data and techniques throughout undergraduate biology education; and establishing mechanisms for the dissemination of bioinformatics resource materials and innovative teaching models.

Jungck and his colleagues will hold a series of faculty development workshops around the country in support of the project.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more